These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 315322)

  • 1. Effects of ergot drugs on serotonergic function: behavior and neurochemistry.
    Silbergeld EK; Hruska RE
    Eur J Pharmacol; 1979 Sep; 58(1):1-10. PubMed ID: 315322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central monoamine synapses as sites of action for ergot drugs.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Hall H; Köhler C; Fredholm B
    Adv Biochem Psychopharmacol; 1980; 23():41-62. PubMed ID: 6104914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids.
    Holohean AM; White FJ; Appel JB
    Eur J Pharmacol; 1982 Jul; 81(4):595-602. PubMed ID: 7117388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome".
    Silbergeld EK; Hruska RE
    Psychopharmacology (Berl); 1979 Nov; 65(3):233-7. PubMed ID: 117494
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of neurotransmitter receptor binding by ergot derivatives.
    Hruska RE; Silbergeld EK
    J Neurosci Res; 1981; 6(1):1-11. PubMed ID: 6111611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex.
    Beart PM; McDonald D; Cincotta M; de Vries DJ; Gundlach AL
    Gen Pharmacol; 1986; 17(1):57-62. PubMed ID: 3949149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.
    Rosenfeld MR; Makman MH; Ahn HS; Thal LJ; Mishra RK; Katzman R
    Adv Biochem Psychopharmacol; 1980; 23():83-93. PubMed ID: 6249092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsensitivity to 5-hydroxytryptamine agonists occurs in streptozocin-diabetic rats with no change in [3H]-5-HT receptor binding.
    Trulson ME; MacKenzie RG
    J Pharm Pharmacol; 1981 Jul; 33(7):472-4. PubMed ID: 6115040
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of serotonergic agents in the clinical assessment of central serotonin function.
    Murphy DL; Mueller EA; Garrick NA; Aulakh CS
    J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
    Trulson ME; Eubanks EE; Jacobs BL
    J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Para-halogenated phenethylamines: similar serotonergic effects in rats by different mechanisms.
    Sloviter RS; Connor JD; Damiano BP; Drust EG
    Pharmacol Biochem Behav; 1980 Aug; 13(2):283-6. PubMed ID: 6447879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.
    Boban Blagaic A; Blagaic V; Mirt M; Jelovac N; Dodig G; Rucman R; Petek M; Turkovic B; Anic T; Dubovecak M; Staresinic M; Seiwerth S; Sikiric P
    Eur J Pharmacol; 2005 Apr; 512(2-3):173-9. PubMed ID: 15840402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of naftidrofuryl oxalate on 5-HT2 receptors in mouse brain: evaluation based on quantitative autoradiography and head-twitch response.
    Nabeshima T; Hiramatsu M; Niwa K; Fuji K; Kameyama T
    Eur J Pharmacol; 1992 Nov; 223(2-3):109-15. PubMed ID: 1478263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin: a possible mediator of behavioral suppression induced by anxiety.
    Wise CD; Berger BD; Stein L
    Dis Nerv Syst; 1970 Nov; 31():Suppl:34-7. PubMed ID: 5312689
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL; Tagliamonte A
    Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
    [No Abstract]   [Full Text] [Related]  

  • 19. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior.
    Robertson B; Baker GB; Vanderwolf CH
    Brain Res; 1991 Aug; 555(2):265-75. PubMed ID: 1933339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.